The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas

Oral Oncology

Volumn 50, Issue 6, 2014, Pages 565-574

  Benson, Eleni ^a   Li, Ryan ^a   Eisele, David ^a   Fakhry, Carole ^a,b,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Milton J Dance Jr Head and Neck Center   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Head and neck cancer; HPV; Oropharyngeal neoplasms; Prognosis; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; CISPLATIN; PLATINUM; PROTEIN E6; PROTEIN E7; RADIOSENSITIZING AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISTANT METASTASIS; EXPOSURE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK BEHAVIOR; HISTOLOGY; HUMAN; IMMUNOSURVEILLANCE; INDUCTION CHEMOTHERAPY; INTERMEDIATE RISK PATIENT; LASER SURGERY; LOW RISK PATIENT; MICROSURGERY; NONHUMAN; ORAL SURGERY; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RACE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SMOKING; SURGICAL TECHNIQUE; TREATMENT RESPONSE; UNITED STATES; VIRUS CARCINOGENESIS; WART VIRUS; ALPHAPAPILLOMAVIRUS; FEMALE; ISOLATION AND PURIFICATION; MALE; OROPHARYNX TUMOR; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RISK FACTORS; SEX FACTORS;

EID: 84900489886     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.09.008     Document Type: Article

References (116)

1. A.G. Sikora, P. Toniolo, and M.D. DeLacure The changing demographics of head and neck squamous cell carcinoma in the United States Laryngoscope 114 11 2004 1915 1923 10.1097/01.mlg.0000147920.66486.bc
2. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2012 [Epub 2012/01/24]. doi: http://dx.doi.org/10.1002/hed. 22015.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-301 [Epub 2011/10/05]. doi: http://dx.doi.org/JCO.2011.36.4596[[pii] 10.1200/JCO.2011.36.4596. PubMed PMID: 21969503; PubMed Central PMCID: PMC3221528].
4. C.H. Shiboski, B.L. Schmidt, and R.C. Jordan Tongue and tonsil carcinoma: increasing trends in the US population ages 20-44 years Cancer 103 9 2005 1843 1849 10.1002/cncr.20998
5. A.D. Colevas Population-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic status, sex, and race/ethnicity Head Neck 2013 10.1002/hed.23253
6. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363(1):24-35 [Epub 2010/06/10]. doi: http://dx.doi.org/NEJMoa0912217 [[pii] 10.1056/NEJMoa0912217. PubMed PMID: 20530316; PubMed Central PMCID: PMC2943767].
7. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010;28(27):4142-8 [Epub 2010/08/11]. doi: http://dx.doi.org/JCO.2010.29.2904 [[pii] 10.1200/JCO.2010.29.2904. PubMed PMID: 20697079; PubMed Central PMCID: PMC2953971].
8. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100(6):407-20 [Epub 2008/03/13]. doi: http://dx.doi.org/djn025 [[pii] 10.1093/jnci/djn025].
9. C. Fakhry, W.H. Westra, S. Li, A. Cmelak, J.A. Ridge, and H. Pinto et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 4 2008 261 269 10.1093/jnci/djn011
10. G. D'Souza, Y. Agrawal, J. Halpern, S. Bodison, and M.L. Gillison Oral sexual behaviors associated with prevalent oral human papillomavirus infection J Infect Dis 199 9 2009 1263 1269 10.1086/597755
11. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, and L. Wu et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 9 2000 709 720
12. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011;333(6046):1154-7 [Epub 2011/07/30]. doi: http://dx.doi.org/science.1206923 [[pii] 10.1126/science. 1206923. PubMed PMID: 21798897; PubMed Central PMCID: PMC3162986].
13. M.R. Posner, J.H. Lorch, O. Goloubeva, M. Tan, L.M. Schumaker, and N.J. Sarlis et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial Ann Oncol 22 5 2011 1071 1077 10.1093/annonc/mdr006
14. Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulhoi BP, Overgaard M, et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol 2011;100(1):49-55 [Epub 2011/03/25]. doi: http://dx.doi.org/S0167-8140(11)00091-0 [[pii] 10.1016/j.radonc.2011.02.010].
15. Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005;11(16):5694-9 [Epub 2005/08/24]. doi: http://dx.doi.org/11/ 16/5694 [[pii] 10.1158/1078-0432.CCR-05-0587].
16. G. D'Souza, A.R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, and W.M. Koch et al. Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 19 2007 1944 1956 10.1056/NEJMoa065497
17. S.K. El-Mofty, M.Q. Zhang, and R.M. Davila Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma Head Neck Pathol 2 3 2008 163 168 10.1007/s12105-008-0066-1 [PubMed PMID: 20614311; PubMed Central PMCID: PMC2807564]
18. J. Vent, B. Haidle, I. Wedemeyer, C. Huebbers, O. Siefer, and R. Semrau et al. P16 Expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker Head Neck 2013 10.1002/hed.23190
19. J.M. Park, C.K. Jung, Y.J. Choi, K.Y. Lee, J.H. Kang, and M.S. Kim et al. The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma Hum Pathol 41 3 2010 431 437 10.1016/j.humpath.2009.09.001
20. S. Begum, M.L. Gillison, T.L. Nicol, and W.H. Westra Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck Clin Cancer Res 13 4 2007 1186 1191
21. M.L. Gillison HPV and prognosis for patients with oropharynx cancer Eur J Cancer 45 Suppl 1 2009 383 385 10.1016/S0959-8049(09)70058-9
22. T. Isayeva, Y. Li, D. Maswahu, and M. Brandwein-Gensler Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review Head Neck Pathol 6 Suppl 1 2012 S104 S120 10.1007/s12105-012- 0368-1 [PubMed PMID: 22782230; PubMed Central PMCID: PMC3394168]
23. M.W. Lingen, W. Xiao, A. Schmitt, B. Jiang, R. Pickard, and P. Kreinbrink et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas Oral Oncol 49 1 2013 1 8 10.1016/j.oraloncology.2012. 07.002
24. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89(3):300-4 [Epub 2000/06/22]. doi: http://dx.doi.org/10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0. CO;2-G [pii].
25. P.M. Weinberger, Z. Yu, B.G. Haffty, D. Kowalski, M. Harigopal, and J. Brandsma et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 5 2006 736 747 10.1200/JCO.2004.00.3335
26. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001;125(1):1-9 [Epub 2001/07/18]. doi: http://dx.doi.org/S0194-5998(01)31813-2 [pii] 10.1067/mhn.2001.116979.
27. B. O'Sullivan, S.H. Huang, L.L. Siu, J. Waldron, H. Zhao, and B. Perez-Ordonez et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis J Clin Oncol 31 5 2013 543 550 10.1200/JCO.2012.44.0164
28. Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008;30(7):898-903 [Epub 2008/04/03]. doi: http://dx.doi.org/10.1002/hed.20796.
29. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Sasaki C, et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res 2004;10(17):5684-91 [Epub 2004/09/10]. doi: http://dx.doi.org/10.1158/1078-0432.CCR-04-0448. 10/17/5684 [pii].
30. A.M. Hong, T.A. Dobbins, C.S. Lee, D. Jones, G.B. Harnett, and B.K. Armstrong et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy Br J Cancer 103 10 2010 1510 1517 10.1038/sj.bjc.6605944 [PubMed PMID: 20959828; PubMed Central PMCID: PMC2990586]
31. P. Attner, J. Du, A. Nasman, L. Hammarstedt, T. Ramqvist, and J. Lindholm et al. Human papillomavirus and survival in patients with base of tongue cancer Int J Cancer 128 12 2011 2892 2897 10.1002/ijc.25625
32. S.G. Patel, and J.P. Shah TNM staging of cancers of the head and neck: striving for uniformity among diversity CA - Cancer J Clin 55 4 2005 242 258 [quiz 61-2, 64]
33. P.A. Hudgins, and M. Gillison Second branchial cleft cyst: not!! AJNR Am J Neuroradiol 30 9 2009 1628 1629 10.3174/ajnr.A1729
34. Koch WM. Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up. Otolaryngol Clin North Am 2012;45(4):779-93 [Epub 2012/07/17]. doi: http://dx.doi.org/S0030-6665(12)00052-7 [pii] 10.1016/j.otc.2012.04.004.
35. A.S. Corey, and P.A. Hudgins Radiographic imaging of human papillomavirus related carcinomas of the oropharynx Head Neck Pathol 6 Suppl 1 2012 S25 S40 10.1007/s12105-012-0374-3 [PubMed PMID: 22782221; PubMed Central PMCID: PMC3394164]
36. Cantrell SC, Peck BW, Li G, Wei Q, Sturgis EM, Ginsberg LE. Differences in imaging characteristics of HPV-positive and HPV-negative oropharyngeal cancers: a blinded matched-pair analysis. AJNR Am J Neuroradiol. 2013 [Epub 2013/05/11] doi: http://dx.doi.org/ajnr.A3524 [pii] 10.3174/ajnr.A3524.
37. W.H. Westra The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management Head Neck Pathol 6 Suppl 1 2012 S48 S54 10.1007/s12105-012-0371-6 [PubMed PMID: 22782223; PubMed Central PMCID: PMC3394160]
38. M. De Petrini, M. Ritta, M. Schena, L. Chiusa, P. Campisi, and C. Giordano et al. Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression The New microbiologica 29 1 2006 25 33
39. B. Kumar, K.G. Cordell, J.S. Lee, F.P. Worden, M.E. Prince, and H.H. Tran et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 19 2008 3128 3137 10.1200/JCO.2007.12.7662 [PubMed PMID: 18474878; PubMed Central PMCID: PMC2744895]
40. F.P. Worden, B. Kumar, J.S. Lee, G.T. Wolf, K.G. Cordell, and J.M. Taylor et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number J Clin Oncol 26 19 2008 3138 3146 10.1200/JCO.2007.12.7597 [PubMed PMID: 18474879; PubMed Central PMCID: PMC2742158]
41. S. Heath, V. Willis, K. Allan, K. Purdie, C. Harwood, and P. Shields et al. Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice Clinical Oncol 24 1 2012 e18 e23 10.1016/j.clon.2011.05.007
42. J.M. Ritchie, E.M. Smith, K.F. Summersgill, H.T. Hoffman, D. Wang, and J.P. Klussmann et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx Int J Cancer 104 3 2003 336 344 10.1002/ijc.10960
43. Kumar B, Cordell KG, Lee JS, Prince ME, Tran HH, Wolf GT, et al. Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S109-11 [Epub 2007/10/18]. doi: http://dx.doi.org/S0360-3016(07)00965-0 [[pii] 10.1016/j.ijrobp.2007.05.072. PubMed PMID: 17848274; PubMed Central PMCID: PMC2084353].
44. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA: J Am Med Assoc 2012; 307(7): 693-703. doi: http://dx.doi.org/10.1001/jama.2012.101.
45. A. Jemal, E.P. Simard, C. Dorell, A.M. Noone, L.E. Markowitz, and B. Kohler et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels J Natl Cancer Inst 105 3 2013 175 201 10.1093/jnci/djs491 [PubMed PMID: 23297039; PubMed Central PMCID: PMC3565628]
46. K. Settle, M.R. Posner, L.M. Schumaker, M. Tan, M. Suntharalingam, and O. Goloubeva et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients Cancer Prevent Res 2 9 2009 776 781 10.1158/1940-6207.CAPR-09-0149
47. P.M. Weinberger, M.A. Merkley, S.S. Khichi, J.R. Lee, A. Psyrri, and L.L. Jackson et al. Human papillomavirus-active head and neck cancer and ethnic health disparities Laryngoscope 120 8 2010 1531 1537 10.1002/lary.20984 [PubMed PMID: 20564751; PubMed Central PMCID: PMC3051373]
48. J.E. Heck, J. Berthiller, S. Vaccarella, D.M. Winn, E.M. Smith, and O. Shan'gina et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium Int J Epidemiol 39 1 2010 166 181 10.1093/ije/dyp350 [PubMed PMID: 20022926; PubMed Central PMCID: PMC2817092]
49. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11(1):9-22 [Epub 2010/12/17]. doi: http://dx.doi.org/nrc2982 [pii] 10.1038/nrc2982.
50. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371(9625):1695-709 [Epub 2008/05/20]. doi: http://dx.doi.org/S0140- 6736(08)60728-X [pii] 10.1016/S0140-6736(08)60728-X.
51. Giovino GA. The tobacco epidemic in the United States. Am J Prev Med. 2007;33(6 Suppl):S318-26 [Epub 2007/12/06]. doi: http://dx.doi.org/S0749- 3797(07)00567-3 [pii] 10.1016/j.amepre.2007.09.008.
52. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114(5):806-16 [Epub 2004/12/21]. doi: http://dx.doi.org/10.1002/ijc.20740.
53. C. Liang, C.J. Marsit, M.D. McClean, H.H. Nelson, B.C. Christensen, and R.I. Haddad et al. Biomarkers of HPV in head and neck squamous cell carcinoma Cancer Res 72 19 2012 5004 5013 10.1158/0008-5472.CAN-11-3277 [PubMed PMID: 22991304; PubMed Central PMCID: PMC3463756]
54. H.C. Hafkamp, J.J. Manni, A. Haesevoets, A.C. Voogd, M. Schepers, and F.J. Bot et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas Int J Cancer 122 12 2008 2656 2664 10.1002/ijc.23458
55. E.M. Smith, L.M. Rubenstein, T.H. Haugen, E. Hamsikova, and L.P. Turek Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers Cancer Cause Contr: CCC 21 9 2010 1369 1378 10.1007/s10552-010-9564-z
56. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 12 2009 1992 1998 10.1200/JCO.2008.20.2853
57. H. Mehanna, C.M. West, C. Nutting, and V. Paleri Head and neck cancer-Part 2: treatment and prognostic factors BMJ 341 2010 c4690 10.1136/bmj.c4690
58. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012;48(12):1191-201 [Epub 2012/07/31]. doi: http://dx.doi.org/S1368-8375(12)00230-8 [pii] 10.1016/j.oraloncology.2012.06. 019.
59. C.A. Fischer, M. Kampmann, I. Zlobec, E. Green, L. Tornillo, and A. Lugli et al. P16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters Ann Oncol 21 10 2010 1961 1966 10.1093/annonc/mdq210
60. J.M. Straetmans, N. Olthof, J.J. Mooren, J. de Jong, E.J. Speel, and B. Kremer Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas Laryngoscope 119 10 2009 1951 1957 10.1002/lary.20593
61. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92(4):805-13 [Epub 2001/09/11]. http://dx.doi.org/10.1002/1097-0142(20010815)92:4<805:: AID-CNCR1386>3.0.CO;2-9 [pii].
62. A.N. Snow, and J. Laudadio Human papillomavirus detection in head and neck squamous cell carcinomas Adv Anat Pathol 17 6 2010 394 403 10.1097/PAP.0b013e3181f895c1
63. K.K. Ang, and E.M. Sturgis Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma Semin Radiat Oncol 22 2 2012 128 142 10.1016/j.semradonc.2011.12.004
64. R.C. Jordan, M.W. Lingen, B. Perez-Ordonez, X. He, R. Pickard, and M. Koluder et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials Am J Surg Pathol 36 7 2012 945 954 10.1097/PAS.0b013e318253a2d1
65. M.A. Cohen, S.R. Basha, D.K. Reichenbach, E. Robertson, and D.A. Sewell Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients Acta Otolaryngol 128 5 2008 583 589 10.1080/00016480701558880
66. G. Fountzilas, P. Kosmidis, V. Avramidis, A. Nikolaou, A. Kalogera-Fountzila, and P. Makrantonakis et al. Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic Co-operative oncology Group study Med Pediatr Oncol 28 6 1997 401 410
67. G.P. Browman, E.A. Mohide, A. Willan, I. Hodson, G. Wong, and L. Grimard et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study Head Neck 24 12 2002 1031 1037 10.1002/hed.10168
68. Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30(17):2102-11 [Epub 2012/05/09] doi: http://dx.doi.org/JCO.2011.38.4099 [[pii] 10.1200/JCO.2011.38.4099. PubMed PMID: 22565003; PubMed Central PMCID: PMC3397696].
69. Hannisdal K, Schjolberg A, De Angelis PM, Boysen M, Clausen OP. Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway. Acta Otolaryngol 2010;130(2):293-9 [Epub 2009/08/15]. http://dx.doi.org/913899438 [pii] 10.3109/00016480903071377.
70. M.A. Molina, M.C. Cheung, E.A. Perez, M.M. Byrne, D. Franceschi, and F.L. Moffat et al. African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients Cancer 113 10 2008 2797 2806 10.1002/cncr.23889
71. T.P. Schrank, Y. Han, H. Weiss, and V.A. Resto Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States-possible role for human papillomavirus in survival disparities Head Neck 33 1 2011 45 53 10.1002/hed.21398 [PubMed PMID: 20848419; PubMed Central PMCID: PMC3005025]
72. M.L. Gillison, L. Alemany, P.J. Snijders, A. Chaturvedi, B.M. Steinberg, and S. Schwartz et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis Vaccine 30 Suppl 5 2012 F34 F54 10.1016/j.vaccine.2012.05.070
73. A.R. Kreimer, C.M. Pierce Campbell, H.Y. Lin, W. Fulp, M.R. Papenfuss, and M. Abrahamsen et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study Lancet 2013 10.1016/S0140-6736(13)60809-0
74. C.H. Chung, and M.L. Gillison Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications Clin Cancer Res 15 22 2009 6758 6762 10.1158/1078-0432.CCR-09-0784
75. K. Strati, and P.F. Lambert Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer Cancer Res 67 24 2007 11585 11593 10.1158/0008-5472.CAN-07-3007 [PubMed PMID: 18089787; PubMed Central PMCID: PMC2859176]
76. M. Thomas, and L. Banks Inhibition of Bak-induced apoptosis by HPV-18 E6 Oncogene 17 23 1998 2943 2954 10.1038/sj.onc.1202223
77. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24(36):5630-6 [Epub 2006/12/21]. doi: http://dx.doi.org/24/36/5630 [[pii] 10.1200/JCO.2005.04. 6136].
78. B.J. Braakhuis, P.J. Snijders, W.J. Keune, C.J. Meijer, H.J. Ruijter-Schippers, and C.R. Leemans et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus J Natl Cancer Inst 96 13 2004 998 1006
79. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333(6046):1157-60 [Epub 2011/07/30]. doi: http://dx.doi.org/science.1208130 [[pii] 10.1126/science.1208130. PubMed PMID: 21798893; PubMed Central PMCID: PMC3415217].
80. A.K. Chaturvedi, E.A. Engels, W.F. Anderson, and M.L. Gillison Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 4 2008 612 619
81. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard et al. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 1 2010 30 35 10.1016/j.radonc.2009.10.008
82. R.J. Kimple, M.A. Smith, G.C. Blitzer, A.D. Torres, J.A. Martin, and R.Z. Yang et al. Enhanced radiation sensitivity in HPV-positive head and neck cancer Cancer Res 2013 10.1158/0008-5472.CAN-13-0587
83. A.K. Gupta, J.H. Lee, W.W. Wilke, H. Quon, G. Smith, and A. Maity et al. Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT Int J Radiat Oncol Biol Phys 74 3 2009 928 933 10.1016/j.ijrobp.2009.03.004 [PubMed PMID: 19480971; PubMed Central PMCID: PMC2766796]
84. T. Rieckmann, S. Tribius, T.J. Grob, F. Meyer, C.J. Busch, and C. Petersen et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Radiother Oncol 107 2 2013 242 246 10.1016/j.radonc.2013.03.013
85. Spanos WC, Nowicki P, Lee DW, Hoover A, Hostager B, Gupta A, et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol-Head Neck Surgery 2009;135(11):1137-46. doi: http://dx.doi.org/10.1001/archoto.2009.159.
86. J.D. Schultz, J.U. Sommer, S. Hoedt, P. Erben, R.D. Hofheinz, and A. Faber et al. Chemotherapeutic alteration of beta-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro Oncol Rep 27 1 2012 270 280 doi: 10.3892/or.2011.1499. PubMed PMID: 21993766.
87. A.L. Tang, J.H. Owen, S.J. Hauff, J.J. Park, S. Papagerakis, and C.R. Bradford et al. Head and neck cancer stem cells: the effect of HPV-an in vitro and mouse study Otolaryngol Head Neck Surg 2013 10.1177/0194599813486599
88. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, et al. Cancer incidence before and after kidney transplantation. JAMA: J Am Med Assoc 2006; 296(23):2823-31. doi: http://dx.doi.org/10.1001/jama.296.23.2823.
89. R. Williams, D.W. Lee, B.D. Elzey, M.E. Anderson, B.S. Hostager, and J.H. Lee Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC Head Neck 31 7 2009 911 918 10.1002/hed.21040
90. Heusinkveld M, Goedemans R, Briet RJ, Gelderblom H, Nortier JW, Gorter A, et al. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int J Cancer 2012;131(2):E74-85 [Epub 2011/10/25]. doi: http://dx.doi.org/10.1002/ijc.26497.
91. A. Albers, K. Abe, J. Hunt, J. Wang, A. Lopez-Albaitero, and C. Schaefer et al. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck Cancer Res 65 23 2005 11146 11155 10.1158/0008-5472.CAN-05-0772
92. H. Mellin, L. Dahlgren, E. Munck-Wikland, J. Lindholm, H. Rabbani, and M. Kalantari et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer Int J Cancer 102 2 2002 152 158 10.1002/ijc.10669
93. B.G. Wieking, D.W. Vermeer, W.C. Spanos, K.M. Lee, P. Vermeer, and W.T. Lee et al. A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors Cancer Gene Ther 19 10 2012 667 674 10.1038/cgt.2012.55 [PubMed PMID: 22918471; PubMed Central PMCID: PMC3571619]
94. D.O. Francis, E.A. Weymuller Jr., U. Parvathaneni, A.L. Merati, and B. Yueh Dysphagia, stricture, and pneumonia in head and neck cancer patients: does treatment modality matter? Ann Otol Rhinol Laryngol 119 6 2010 391 397
95. J.A. Langendijk, P. Doornaert, I.M. Verdonck-de Leeuw, C.R. Leemans, N.K. Aaronson, and B.J. Slotman Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 26 22 2008 3770 3776 10.1200/JCO.2007.14.6647
96. C.A. Rabik, and M.E. Dolan Molecular mechanisms of resistance and toxicity associated with platinating agents Cancer Treat Rev 33 1 2007 9 23 10.1016/j.ctrv.2006.09.006 [PubMed PMID: 17084534; PubMed Central PMCID: PMC1855222]
97. Quon H, Richmon JD. Treatment deintensification strategies for HPV-associated head and neck carcinomas. Otolaryngol Clin North Am. 2012;45(4):845-61 [Epub 2012/07/17]. doi: http://dx.doi.org/S0030-6665(12)00055- 2 [pii] 10.1016/j.otc.2012.04.007.
98. National Comprehensive Cancer N. Head and Neck Cancers 2013 [6/14/2013]. Version 2.2013: [Available from: http://www.nccn.org/professionals/physician- gls/pdf/head-and-neck.pdf ].
99. G.S. Weinstein, H. Quon, B.W. O'Malley Jr., G.G. Kim, and M.A. Cohen Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial Laryngoscope 120 9 2010 1749 1755 10.1002/lary.21021
100. Weinstein GS, O'Malley BW, Jr, Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Archiv Otolaryngol-Head Neck, Surgery 2010;136(11):1079-85. doi: http://dx.doi.org/10.1001/archoto.2010.191.
101. A.R. Sedaghat, Z. Zhang, S. Begum, R. Palermo, S. Best, and K.M. Ulmer et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas Laryngoscope 119 8 2009 1542 1549 10.1002/lary.20533
102. S.H. Huang, B. Perez-Ordonez, F.F. Liu, J. Waldron, J. Ringash, and J. Irish et al. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy Int J Radiat Oncol Biol Phys 82 1 2012 276 283 10.1016/j.ijrobp.2010.08.031
103. T. Andl, T. Kahn, A. Pfuhl, T. Nicola, R. Erber, and C. Conradt et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control Cancer Res 58 1 1998 5 13
104. W. Li, C.H. Thompson, C.J. O'Brien, E.B. McNeil, R.A. Scolyer, and Y.E. Cossart et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil Int J Cancer 106 4 2003 553 558 10.1002/ijc.11261
105. N. Reimers, H.U. Kasper, S.J. Weissenborn, H. Stutzer, S.F. Preuss, and T.K. Hoffmann et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 8 2007 1731 1738 10.1002/ijc.22355
106. D. Lindquist, M. Romanitan, L. Hammarstedt, A. Nasman, H. Dahlstrand, and J. Lindholm et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 Mol Oncol 1 3 2007 350 355 10.1016/j.molonc.2007.08.005
107. J. Klozar, V. Kratochvil, M. Salakova, J. Smahelova, E. Vesela, and E. Hamsikova et al. HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer European Arch oto-rhino-Laryngol: Off J Eur Fed Oto-Rhino-Laryngol Soc 265 Suppl 1 2008 S75 S82 10.1007/s00405-007-0557-9
108. E.M. Smith, D. Wang, Y. Kim, L.M. Rubenstein, J.H. Lee, and T.H. Haugen et al. P16INK4a expression, human papillomavirus, and survival in head and neck cancer Oral Oncol 44 2 2008 133 142 10.1016/j.oraloncology.2007.01.010
109. C.Y. Chien, C.Y. Su, F.M. Fang, H.Y. Huang, H.C. Chuang, and C.M. Chen et al. Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan Oral Oncol 44 2 2008 174 179 10.1016/j.oraloncology.2007.01.018
110. C.A. Fischer, I. Zlobec, E. Green, S. Probst, C. Storck, and A. Lugli et al. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int J Cancer 126 5 2010 1256 1262 10.1002/ijc.24842
111. A.C. Jung, J. Briolat, R. Millon, A. de Reynies, D. Rickman, and E. Thomas et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma Int J Cancer 126 8 2010 1882 1894 10.1002/ijc.24911
112. A. Hong, T. Dobbins, C.S. Lee, D. Jones, E. Jackson, and J. Clark et al. Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer Eur J Cancer 46 11 2010 2088 2096 10.1016/j.ejca.2010.04.016
113. A.M. Hong, T.A. Dobbins, C.S. Lee, D. Jones, J. Fei, and J.R. Clark et al. Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer Int J Cancer 128 7 2011 1532 1545 10.1002/ijc.25479
114. S. Sethi, R. Ali-Fehmi, S. Franceschi, L. Struijk, L.J. van Doorn, and W. Quint et al. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study Int J Cancer 131 5 2012 1179 1186 10.1002/ijc.26500 [PubMed PMID: 22020866; PubMed Central PMCID: PMC3319485]
115. Z. Deng, M. Hasegawa, Y. Yamashita, S. Matayoshi, A. Kiyuna, and S. Agena et al. Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma Cancer Sci 103 12 2012 2127 2134 10.1111/cas.12009
116. K. Park, K.J. Cho, M. Lee, D.H. Yoon, J. Kim, and S.Y. Kim et al. P16 immunohistochemistry alone is a better prognosticator in tonsil cancer than human papillomavirus in situ hybridization with or without p16 immunohistochemistry Acta Otolaryngol 133 3 2013 297 304 10.3109/00016489.2012. 741327